The Role of miRNA-7 in the Biology of Cancer and Modulation of Drug Resistance
- PMID: 33673265
- PMCID: PMC7918072
- DOI: 10.3390/ph14020149
The Role of miRNA-7 in the Biology of Cancer and Modulation of Drug Resistance
Abstract
MicroRNAs (miRNAs, miRs) are small non-coding RNA (ncRNA) molecules capable of regulating post-transcriptional gene expression. Imbalances in the miRNA network have been associated with the development of many pathological conditions and diseases, including cancer. Recently, miRNAs have also been linked to the phenomenon of multidrug resistance (MDR). MiR-7 is one of the extensively studied miRNAs and its role in cancer progression and MDR modulation has been highlighted. MiR-7 is engaged in multiple cellular pathways and acts as a tumor suppressor in the majority of human neoplasia. Its depletion limits the effectiveness of anti-cancer therapies, while its restoration sensitizes cells to the administered drugs. Therefore, miR-7 might be considered as a potential adjuvant agent, which can increase the efficiency of standard chemotherapeutics.
Keywords: cancer; miR-7; multidrug resistance.
Conflict of interest statement
All Authors declare no conflict of interest.
Figures



Similar articles
-
miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.Cancer Chemother Pharmacol. 2012 Mar;69(3):723-31. doi: 10.1007/s00280-011-1752-3. Epub 2011 Oct 13. Cancer Chemother Pharmacol. 2012. PMID: 21993663
-
miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2.Biochem J. 2012 Sep 1;446(2):291-300. doi: 10.1042/BJ20120386. Biochem J. 2012. PMID: 22676135
-
miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo.Mol Oncol. 2017 Feb;11(2):151-166. doi: 10.1002/1878-0261.12015. Epub 2016 Oct 24. Mol Oncol. 2017. PMID: 28145098 Free PMC article. Clinical Trial.
-
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.Eur J Cancer. 2010 Jan;46(2):298-311. doi: 10.1016/j.ejca.2009.10.027. Epub 2009 Nov 28. Eur J Cancer. 2010. PMID: 19948396 Review.
-
The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma.Cancers (Basel). 2019 Nov 6;11(11):1738. doi: 10.3390/cancers11111738. Cancers (Basel). 2019. PMID: 31698726 Free PMC article. Review.
Cited by
-
Towards Unravelling the Role of ERα-Targeting miRNAs in the Exosome-Mediated Transferring of the Hormone Resistance.Molecules. 2021 Nov 3;26(21):6661. doi: 10.3390/molecules26216661. Molecules. 2021. PMID: 34771077 Free PMC article.
-
Identification of TIMP1-induced dysregulation of epithelial-mesenchymal transition as a key pathway in inflammatory bowel disease and small intestinal neuroendocrine tumors shared pathogenesis.Front Genet. 2024 Aug 21;15:1376123. doi: 10.3389/fgene.2024.1376123. eCollection 2024. Front Genet. 2024. PMID: 39233736 Free PMC article.
-
A thematic analysis of prognostic, diagnostic, and therapeutic of circulating miRNA biomarkers in bortezomib-resistant multiple myeloma.SAGE Open Med. 2025 Apr 26;13:20503121251328486. doi: 10.1177/20503121251328486. eCollection 2025. SAGE Open Med. 2025. PMID: 40297788 Free PMC article. Review.
-
Low expression of miR-7-5p promotes resistance to radiotherapy in lung cancer through direct upregulation of PKP2 expression.Sci Rep. 2025 May 15;15(1):16847. doi: 10.1038/s41598-025-01001-6. Sci Rep. 2025. PMID: 40374728 Free PMC article.
-
Pan-Cancer Analysis Reveals the Relation between TRMT112 and Tumor Microenvironment.J Oncol. 2022 Aug 30;2022:1445932. doi: 10.1155/2022/1445932. eCollection 2022. J Oncol. 2022. PMID: 36081672 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources